During antibiotic therapy for serious Haemophilus influenzae type b infections in children, respiratory mucosal colonization with this organism is suppressed but not eradicated. To define possible mechanisms contributing to this suppression, the ability of six antibiotics to influence the adherence of H. influenzae type b to human epithelial cells was investigated. In assays in which the organisms were grown in broth containing 0.5 x the MIC of rifampin, ampicillin, clindamycin, chloramphenicol, lincomycin, or trimethoprimsulfamethoxazole, all drugs except rifampin significantly reduced bacterial adherence. In assays in which nonreplicating organisms were exposed to the antibiotics, all six drugs reduced the adherence of the bacteria.
0.5 x the MIC of rifampin, ampicillin, clindamycin, chloramphenicol, lincomycin, or trimethoprimsulfamethoxazole, all drugs except rifampin significantly reduced bacterial adherence. In assays in which nonreplicating organisms were exposed to the antibiotics, all six drugs reduced the adherence of the bacteria.
In assays ip which the epithelial cells were exposed to Haemophilus influenzae type b, a common cause of serious childhood bacterial infections, including meningitis, epiglottitis, septic arthritis, pneumonia, and cellulitis, colonizes the mucosa of the upper respiratory tract as the initial event in the establishment of infection (11) . Attempts to prevent serious H. influenzae type b infections in children have included the use of antibiotics to eradicate nasopharyngeal colonization with this organism. Although a number of orally administered antibiotics, including ampicillin (1, 4) , cefaclor (7, 21) , trimethoprim-sulfamethoxazole (20) , and erythromycin-sulfisoxazole (7) , have failed to eradicate mucosal colonization, rifampin has been shown to be effective (5, 7) . Although H. influenzae type b is often cultured from the nasopharynges of children with serious systemic H. influenzae type b infections before the initiation of intravenous antibiotic therapy, the organism often is not isolated during therapy (2) . However, after discontinuation of antibiotic therapy that successfully treated infections with ampicillin (10) (19) , and subinhibitory concentrations of antibiotics (12, 14, 18 (16) organisms grown in rifampin, an antibiotic that blocks bacterial protein synthesis, showed no decrease in adherence. Thus, in addition to decreased pilus production, steric hindrance of the bacterial binding sites by antibiotic molecules may be another mechanism of adherence inhibition. On the basis of our results, we cannot speculate on the specificity of this interaction at the bacterial binding sites.
The observation that epithelial cells pretreated with antibiotics bound H. influenzae type b less well than did untreated cells suggests that binding sites on epithelial cells are also blocked by antibiotics. In addition, the exposure of epithelial cells with adherent H. influenzae type b to antibiotics led to a decrease in the number of adherent organisms. The biologic phenomena responsible for this apparent release of adherent organisms are unclear. Thus, our data suggest that any of the postulated mechanisms operate in the inhibition of H. influenzae type b adherence by antibiotics.
Because the drugs were not removed after exposure to nonreplicating bacteria in assay 2, the inhibition of the adherence that occurred may have been the result of the drugs interacting with the epithelial cells during the adherence assay incubation step rather than a result of the drugs binding to the bacteria. However, we noted that the adherence was dramatically inhibited by exposing nonreplicating H. influenzae type b to rifampin, clindamycin, and lincomycin but was not inhibited by exposing epithelial cells to these drugs, suggesting that the drugs interact with the bacterial binding sites but not with the epithelial cell receptors.
In choosing a standard amount of drug to be used in each type of experiment, we selected 0.5 x the MIC to avoid levels that would kill the organism. Because our test organism was very resistant to lincomycin (MIC, 128.0 ,ug/ml), the concentration of this drug in our assays was considerably higher than those of the other drugs, and this could explain the profound inhibitory effect observed with lincomycin. However, a marked inhibitory effect was observed with chloramphenicol, and a somewhat lesser effect was observed with clindamycin. Both drugs had lower MICs (2.0 and 8.0 p.g/ml, respectively) than that of lincomycin and thus were present in the assays at lower concentrations.
Two methods of expressing results (the mean number of organisms per epithelial cell and the mean number of epithelial cells with greater than five adherent bacteria) were examined. Both methods reflect the number, avidity, and affinity of binding sites on both the bacteria and the epithelial cells. Results expressed in these two ways show a high degree of concordance, suggesting that the methods measured the same phenomena.
The results from the adherence assay show a considerable degree of variability, possibly because of differing cell types among the epithelial cells, day-to-day differences in the intraoral environment of the epithelial cells, and other, unrecognized factors. Thus, the statistically insignificant inhibitory effect of ampicillin in assay 2 and of chloramphenicol in assay 4 may have been related to this high variability and to the relatively low number of trials (n = 4), as suggested by the wide 95% confidence levels.
In summary, antibiotics appear to inhibit the adherence of H. influenzae type b to human epithelial cells, and this inhibition appears to be independent of the antibiotic killing of the actively metabolizing bacteria. The inhibition of adherence may be the result of several effects of the antibiotics, including decreased production of the pilus protein as a result of depressed bacterial protein synthesis, as has been previously described. Our data suggest that steric hindrance of adherence at the bacterial or epithelial cell binding sites may be another mechanism. This decreased adherence of H. influenzae type b in the presence of antibiotics may explain the suppression of mucosal colonization observed during antibiotic therapy of systemic H. influenzae type b infections. The inhibitory effect of rifampin, a drug that successfully eradicates mucosal colonization, was not greater than that seen with other drugs, such as ampicillin and chloramphenicol, which suppress but do not eradicate colonization.
